- About the Center
- Patient Care
- Community Outreach
- Academic Programs
- News & Media
Yves A. Lussier, MD, FAMCI, a professional engineer and physician-scientist who conducts research in translational bioinformatics and personal genomics, has joined the University of Arizona Cancer Center.
Thomas P. Miller, MD, has been named the director of the Division of Hematology/Oncology in the UA College of Medicine’s Department of Medicine.
Researchers and clinicians at the University of Arizona Cancer Center are responsible for countless scientific breakthroughs, while helping to improve the standard of care for cancer patients throughout the world. These advances, however, are just the first steps toward achieving the ultimate goal — to prevent and cure cancer.
The UACC's Skin Cancer Institute's fourth annual Melanoma Walk set attendance and donation records as more than 400 people hit the street in support of melanoma research, outreach, education and patient care.
While Thomas Grogan, MD, was in the process of redefining tissue analysis, he teamed up with a clinical oncologist in Thomas Miller, MD, to see how they could effectively turn their lymphoma-based research into life-saving therapies.
University of Arizona Cancer Center member Gregory Rogers, PhD, has recently published a paper in the journal Current Biology, highlighting his laboratory’s innovative work exploring the link between the Polo-like kinase 4 (Plk4) protein levels and chromosomal instability (CIN), which can contribute to the formation of cancer.
UA Cancer Center member Terry A. Badger, PhD, RN, PMHCNS-BC, FAAN, is leading a research study to evaluate the impact of low cost telephone-delivered counseling on quality of life for Latinas with breast cancer.
Early in the 21st century, the National Cancer Institute hoped to establish personalized, individually tailored treatment as the standard of care for all cancer patients. With the human genome successfully sequenced in 2003, researchers were given the key that would go toward identifying an individual’s susceptibility for specific forms of cancer, along with the treatment options that would give each patient the best chance of success.